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Novelty and impact: This is one of the largest studies of its kind and, given that an outright ban is unlikely, it 
is important because it suggests that exercise reduces the risks of all-cause, cardiovascular disease, and cancer 
mortality by around 30% in smokers and ex-smokers.  
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Abstract 
 
Exercise is associated with reduced risks of all-cause, cardiovascular disease (CVD), and cancer mortality; 
however, the benefits in smokers and ex-smokers are unclear. The aim of this study was to investigate 
associations between exercise, smoking habit and mortality. Self-reported exercise and smoking, and all-
cause, CVD, and cancer mortality were assessed in 106,341 adults in the Health Survey for England and the 
Scottish Health Survey. There were 9149 deaths from all causes, 2839 from CVD, and 2634 from cancer 
during 999,948 person-years of follow-up. Greater amounts of exercise were associated with decreases and 
greater amounts of smoking were associated with increases in the risks of mortality from all causes, CVD and 
cancer. These associations were additive, with threefold increases in those who did not exercise and smoked. 
In the subgroup of 26,768 ex-smokers, the all-cause mortality hazard ratio was 0.70 (95% CI: 0.60, 0.80), the 
CVD mortality hazard ratio was 0.71 (0.55, 092), and the cancer mortality hazard ratio was 0.66 (0.52, 0.84) 
in those who exercised compared to those who did not. In the subgroup of 28,440 smokers, the all-cause 
mortality hazard ratio was 0.69 (0.57, 0.83), the CVD mortality hazard ratio was 0.66 (0.45, 0.96), and the 
cancer mortality hazard ratio was 0.69 (0.51, 0.94) in those who exercised compared to those who did not. 
Nicotine is addictive and ex-smokers and those who are unwilling or unable to quit could be encouraged to 
exercise in order to reduce the risks of all-cause, CVD and cancer mortality by around 30%. 
 
  
3  
Introduction 
 
Leisure-time physical activity, or exercise, is associated with reduced risks of mortality from all causes, 
cardiovascular disease (CVD) and cancer.1 Cigarette smoking is associated with increased risk of mortality 
from all causes, CVD and cancer.2, 3 Together, lack of exercise and smoking are among the leading causes of 
death in the United Kingdom and high-income countries.4 The prevalence of physical inactivity is around 37% 
in the United Kingdom, where inactivity is defined as not achieving 150 minutes of moderate-intensity 
activity or 75 minutes of vigorous-intensity activity per week, or an equivalent combination.5 The United 
Kingdom government banned smoking in enclosed public places and in the workplace in July 2007. Since 
then, the prevalence of smoking in adults in England has fallen from around 25% to around 18%.6 While 
much has been done to tackle smoking in the United Kingdom, relatively little has been done to tackle 
physical inactivity.7, 8 Physical inactivity costs the UK healthcare system at least INT$1.8 billion per year9 and 
policy makers have been urged to take physical inactivity more seriously.10 Nicotine is a highly addictive 
substance11 and around 60% of smokers continue to say that they have not tried to give up in the previous 12 
months.6 In a study of 17,944 middle-aged men followed for 8.5 years, Morris and colleagues12 reported that 
coronary heart disease incidence was lower in ex-smokers and smokers who took part in vigorous exercise 
than in those who did not. An outright ban on smoking might be regarded as an unacceptable loss of freedom 
in a liberal society;13 however, governments could promote exercise if there was more evidence of the benefits 
in ex-smokers and smokers. The objective of this study was to investigate associations between exercise, 
smoking and all-cause, CVD and cancer mortality using a pooled analysis of eight population-based cohorts in 
Britain.  
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Materials and methods 
 
Participants 
 
The Health Survey for England (HSE) and the Scottish Health Survey (SHS) are household-based surveillance 
studies that are described in detail elsewhere.14, 15 Participants in the present study were derived from surveys 
in 1994 (HSE only), 1995 (SHS only), 1998, 1999 (HSE only), 2003, and 2004 (HSE only). The response 
rates in these surveys were from 66% to 81%, where response rate is defined as the proportion of eligible 
households that took part. The same organization carried out the surveys using consistent methods.14, 15 The 
HSE and SHS samples were selected using a multistage, stratified probability design to be representative of 
the target populations of the corresponding countries. Stratification was based on geographical areas and not 
on individual characteristics: postcode (zip code) sectors were selected at the first stage and household 
addresses selected at the second stage. Local research ethics committees approved all aspects of each survey 
and all participants gave written informed consent.  
 
Physical activity, exercise and smoking 
 
The questionnaires used to assess physical activity and exercise in the HSE and SHS surveys are described in 
detail elsewhere.16, 17 Trained interviewers asked about physical activity and the validity and reliability of the 
physical activity questionnaires have been reported.16, 17 The questions were about the frequency (number of 
days in the last four weeks) and duration (of an average episode) of participation in: domestic physical 
activity; light-intensity (slow/average pace) and moderate-intensity (fairly brisk/fast pace) walking; and type-
specific sports and exercises. For sports and exercises, there was a follow-up question about relative intensity: 
‘Was the effort of [activity] usually enough to make you out of breath or sweaty?’ One metabolic equivalent 
(MET) is considered to represent resting energy expenditure and activities can be quantified in terms of 
multiples of resting energy expenditure. For example, brisk walking is defined as 3.8 METs and jogging as 8 
METs.18 We defined exercise as activities of vigorous or very vigorous intensity (energy expenditure rate of 
≥6 METs). A MET-hour was computed by multiplying the MET score of an activity by the time (in hours). 
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We computed total exercise-related energy expenditure (expressed in MET-hours) by summing the MET-
hours rate of all activities with energy expenditure rate of ≥6 METs.  
 
Trained interviewers also asked about smoking. Participants were first asked, ‘Have you ever smoked a 
cigarette, a cigar or a pipe?’ If participants answered yes, they were then asked, ‘Do you smoke cigarettes at 
all nowadays?’ If yes, they were asked, ‘About how many cigarettes a day do you usually smoke on 
weekdays?’ And, ‘About how many cigarettes a day do you usually smoke at weekends?’ Participants who 
rolled their own cigarettes were asked to estimate tobacco consumption in grams or ounces. The concentration 
of cotinine in saliva, plasma or urine might best be used to distinguish smokers and non-smokers.19 Salivary 
cotinine concentration was measured in 31,007 participants in the HSE (1998, 1999, 2003, 2004) and SHS 
(1998, 2003) and the Person’s correlation between the salivary cotinine concentration and the five self-
reported smoking categories was 0.78 (p<0.001),20 a large effect.21, 22  
 
Covariates 
 
Health status was assessed by asking participants whether they had ‘any longstanding illness, disability of 
infirmity.’ Socioeconomic status assessed using the four group version of the Registrar General’s 
classification: professional and managerial occupations; skilled, non-manual occupations; skilled manual 
occupations; and, routing and manual occupations.  
 
Mortality follow-up 
 
Participants were flagged by the British National Health Service Central Registry. For participants who 
survived, the data were censored up to the end of 2009 (Scottish Health Survey) or the first quarter of 2011 
(Health Survey for England). Diagnoses for the primary cause of death were based on the International 
Classification of Diseases, Ninth (ICD-9) and Tenth (ICD-10) Revisions. Codes corresponding to 
cardiovascular disease (CVD) mortality were 390-459 for ICD-9 and I01-I99 for ICD-10. Codes 
corresponding to cancer mortality were 140-239 for ICD-9 and C00-D48 for ICD-10.  
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Statistical analysis 
 
The Cox proportional hazards model was used to estimate the single or joint effect of different amounts of 
exercise and smoking on the risks of all-cause mortality, CVD mortality, and cancer mortality. We compared 
those who reported no exercise, those who reported less than 60 minutes per week, and those who reported at 
least 60 minutes per week because adults used to be encouraged to take part in 20-60 minutes of vigorous 
exercise three or more times per week.23, 24 In the analyses that were specific to the subgroups of ex-smokers 
and smokers, we treated exercise participation in a dichotomous fashion to preserve statistical power. We also 
calculated the associations between total physical activity energy expenditure and all-cause mortality, CVD 
mortality in ex-smokers and smokers. Domestic activity was not included in the present analysis because of 
the reported lack of an association between domestic activity and mortality.25, 26 The proportional hazards 
assumption was examined by comparing the cumulative hazard plots grouped on exposure, although no 
appreciable violations were noted. For the present analyses, calendar time (months) was the timescale. For the 
present analysis, we excluded those who died during the first 24 months of follow-up. All analyses were 
adjusted for age, sex, occupational social class, longstanding illness and, where appropriate, mutually for 
either smoking or exercise. The association between salivary cotinine and mortality was investigated in a 
sensitivity analysis.  All analyses were performed using SPSS version 22 (IBM Inc.).  
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Results 
 
There were 106,341 participants included in the present study. Seventy-one percent reported no exercise, 12% 
reported less than 60 minutes per week, and 17% reported at least 60 minutes per week. Table 1 shows 
participants’ characteristics at baseline according to exercise habit. Age was 51±17 years in those who 
reported no exercise, 37±13 years in those who reported at least 60 minutes per week, and 47±17 years 
overall. Forty-six percent of participants were male, including 43% of those who reported no exercise and 
57% of those who reported at least 60 minutes per week. Forty-eight percent of participants never smoked, 
including 44% of those who reported no exercise and 58% of those who reported at least 60 minutes per week. 
Ninety-one percent of participants were of white European ethnic origin. Around a third of participants were 
employed in professional and managerial occupations. Fifty-six percent of participants reported no 
longstanding illness, including 51% of those who reported no exercise and 71% of those who reported at least 
60 minutes per week. Table S1 in the online supplement shows cotinine levels and smoking habit. Salivary 
cotinine reflects nicotine exposure in the last 24 hours and, by that definition, misclassification was 3.1% in 
those categorized as never regular smokers, 9.5% in those categorized as ex-smokers, and 5.4% in those 
categorized as smokers. Table S2 shows cotinine concentration, age, the proportion in professional and 
managerial occupations, and exercise habit in smokers.  
 
There were 9149 deaths from all causes, 2839 deaths from CVD, and 2634 deaths from cancer during 999,948 
person-years of follow-up (mean±SD: 9.4±4.5 years). Table 2 shows the independent associations of exercise, 
smoking and mortality. Compared with those who reported no exercise, the hazard ratio for all-cause 
mortality was 0.72 (95% CI: 0.64, 0.81) in those who reported up to 60 minutes per week of exercise, and 
0.69 (95% CI: 0.61, 0.78) in those who reported at least 60 minutes per week of exercise. Greater amounts of 
exercise were also associated with clear decreases in the risks of mortality from CVD and cancer. Compared 
with those who reported never smoking, the hazard ratio for all-cause mortality was 1.59 (95% CI: 1.49, 1.74) 
in those who reported smoking less than 10 cigarettes per day, and 2.86 (95% CI: 2.65, 3.08) in those who 
reported smoking 20 or more cigarettes per day. Greater amounts of smoking were also associated with clear 
increases in the risks of mortality from CVD and cancer.  
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Table 3 shows combined associations of exercise, smoking and mortality. Compared with those who reported 
at least 60 minutes per week of exercise and never smoking, the all-cause mortality hazard ratio was 1.20 
(95% CI: 0.92, 1.57) in those who reported up to 60 minutes per week of exercise and never smoking, and 
1.56 (95% CI, 1.28, 1.91) in those who reported no exercise and never smoking. Lower amounts of exercise 
were associated with clear increases in all-cause mortality risk in ex-smokers and current smokers. Compared 
with those who reported at least 60 minutes per week of exercise and never smoking, the CVD mortality 
hazard ratio was 0.90 (95% CI: 0.59, 1.64) in those who reported up to 60 minutes per week of exercise and 
never smoking, and 2.01 (95% CI: 1.33, 3.06) in those who reported no exercise and never smoking. Lower 
amounts of exercise were associated with clear increases in CVD mortality risk in ex-smokers and current 
smokers. Compared with those who reported at least 60 minutes per week of exercise and never smoking, the 
cancer mortality hazard ratio was 1.73 (95% CI: 1.19, 2.54) in those who reported up to 60 minutes per week 
of exercise and never smoking, and 1.39 (95% CI: 1.02, 1.90) in those who reported no exercise and never 
smoking. Lower amounts of exercise were associated with increases in cancer mortality risk in ex-smokers 
and, particularly, current smokers. 
 
Table 4 shows the association between exercise and mortality in the subgroup of 26,768 ex-smokers, 24% of 
whom reported taking part in exercise. Compared with ex-smokers who reported no exercise, the all-cause 
mortality hazard ratio was 0.70 (95% CI: 0.60, 0.80) in ex-smokers who exercised. The associations between 
exercise and CVD mortality and exercise and cancer mortality were of similar magnitudes. Table 4 also shows 
the association between total physical activity energy expenditure and mortality in ex-smokers. Greater 
amounts of physical activity were associated with decreases in the risks of all-cause mortality and CVD 
mortality. Physical activity energy expenditure per se was not associated with cancer mortality risk.  
 
Table 5 shows the association between exercise and mortality in the subgroup of 28,440 smokers, 24% of 
whom reported taking part in exercise. Compared with smokers who reported no exercise, the all-cause 
mortality hazard ratio was 0.69 (95% CI: 0.57, 0.83) in smokers who exercised. The associations between 
exercise and CVD mortality and exercise and cancer mortality were of similar magnitudes. Table 5 also shows 
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the association between total physical activity energy expenditure and mortality in ex-smokers. Physical 
activity was associated with decreases in the risks of all-cause mortality and CVD mortality. Physical activity 
per se was not associated with decreased risk of cancer mortality. 
 
Selected results are reported in the online supplement. Table S3 shows that the associations between exercise 
and all-cause mortality were similar across surveys and survey years. Table S3 also shows that the 
associations between smoking and all-cause mortality were similar across surveys and survey years. Table S4 
shows that the combined associations of exercise, smoking and all-cause mortality were similar after further 
adjustment for body mass index, diabetes and CVD. Table S5 shows the association between salivary cotinine 
and mortality. Cotinine concentration was associated with increased all-cause mortality risk, increased CVD 
mortality risk, and increased cancer mortality risk. Table S6 shows the combined associations of exercise, 
salivary cotinine and all-cause mortality. Compared with those with a salivary cotinine concentration <0.70 
μg·ml-1 who reported at least 60 minutes per week of exercise (the reference group), the all-cause mortality 
hazard ratio was 1.46 (95% CI: 0.46, 2.75) in those with a salivary concentration of ≥15.0 μg·ml-1 who 
reported at least 60 minutes per week of exercise, 1.90 (95% CI: 1.05, 3.41) in those with a salivary 
concentration of ≥15.0 μg·ml-1 who reported up to 60 minutes per week of exercise, and 2.66 (95% CI: 1.90, 
3.71) in those with a salivary concentration of ≥15.0 μg·ml-1 who reported no exercise (a salivary cotinine 
concentration of ≥15 μg·ml-1 is indicative of cigarette smoking in the last 24 hours). Compared with the 
reference group, the all-cause mortality hazard ratio was 1.42 (95% CI: 1.01, 2.00) in those with a salivary 
concentration of 0.71-14.99 μg·ml-1 who reported no exercise (such salivary cotinine concentrations might be 
indicative of passive smoking). Table S7 shows the associations between exercise, physical activity and 
mortality in those who reported having never smoked regularly. Exercise was associated with lower all-cause 
mortality risk, lower CVD mortality risk, and lower cancer mortality risk. Greater amounts of physical activity 
were associated with decreases in the risks of all-cause mortality and CVD mortality. Physical activity energy 
expenditure per se was not associated with decreased cancer mortality risk in those who reported having never 
smoked regularly.  
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Discussion 
 
The objective of this study was to investigate associations between exercise, smoking and mortality. We 
found that greater amounts of exercise were associated with decreases and greater amounts of smoking were 
associated with increases in the risks of mortality from all causes, CVD and cancer. Importantly, we also 
found that the risks of mortality from all causes, CVD and cancer were reduced by approximately 30% in ex-
smokers and smokers who reported taking part in exercise compared to those who did not.  
 
Nicotine is a highly addictive substance and smoking is one of the most prevalent addictions all over the 
world.11 Around two thirds of smokers are unwilling or unable to give up6 and an outright ban is one of the 
few options left to governments and policy makers in the United Kingdom and elsewhere.27 An outright ban 
may not be a realistic option in a liberal society,13 and the present study is important because it suggests that 
exercise could be promoted as a way of reducing all-cause, CVD and cancer mortality risks in ex-smokers and 
smokers. The World Health Organisation recommends that individuals aged 18 to 64 years should do at least 
150 minutes per week of moderate-intensity aerobic activity or at least 75 minutes per week of vigorous-
intensity aerobic activity.28 The present study suggests that vigorous-intensity physical activity is particularly 
important because overall physical activity energy expenditure was not associated with reduced risk of cancer 
mortality in ex-smokers, smokers, and those who reported having never smoked regularly. Vigorous-intensity 
exercise increases cardiorespiratory fitness more than the same amount of moderate-intensity exercise29-31 and 
low cardiorespiratory fitness may be a stronger predictor of mortality than smoking, obesity and other 
traditional risk factors.32, 33 The Nuffield Council on Bioethics ‘Intervention Ladder’ shows the options 
available to governments and policy makers, from providing information and enabling choice to guiding 
choice and restricting choice.27 Many of the options available to reduce smoking have been successfully 
implemented.13 Few of the options available to increase physical activity have been implemented7, 8 and it is 
unclear how physical activity might be increased in smokers or the general population.  
 
Morris and colleagues12 investigated the relationship between vigorous-intensity exercise in leisure-time and 
coronary heart disease in white-collar workers in the British Civil Service. They observed that age-adjusted 
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coronary heart disease incidence was 2.1% in ex-smokers who reported taking part in vigorous-intensity 
exercise and 5.1% in ex-smokers who did not report taking part in vigorous-intensity exercise. Morris and 
colleagues12 also observed that age-adjusted coronary heart disease incidence was 4.9% in smokers who 
reported taking part in vigorous-intensity exercise and 9.7% in smokers who did not report taking part in 
vigorous-intensity exercise. Li and colleagues34 searched the literature to 28 February 2015 and included 32 
studies in their meta-analysis. Occupational activities, activities of daily living, and leisure-time activities 
were combined and the pooled relative risk of cancer mortality was 0.80 (95% CI: 0.76-0.85) for the highest 
versus the lowest physical activity group.34 The authors did not compare smokers, ex-smokers, and non-
smokers in the pooled or subgroup analyses.34 
 
To the best of our knowledge, the present study includes one of the largest comparisons of mortality risks in 
smokers and ex-smokers who do and do not exercise. The only larger study we are aware of is that of Moore 
and colleagues.35 Moore and colleagues35 pooled data from six prospective cohort studies in the United States 
and observed that the hazard ratio for mortality was 0.75 (95% CI: 0.71-0.79) in smokers and 0.63 (95% CI: 
0.61-0.65) in ex-smokers who reported 7.5-14.9 MET-hours per week of leisure-time physical activity 
compared to those who reported none (here, 7.5 MET-hours per week was equivalent to around 150 minutes 
of moderate-intensity or 75 minutes of vigorous-intensity physical activity). The associations we have 
observed are biologically plausible. It is well documented that exercise training increases insulin sensitivity, 
reduces markers of inflammation, reduces blood pressure, improves vascular function, and improves lipids 
and lipoproteins in the general population.36 Similar evidence is accumulating in smokers.37-39 The present 
study also includes a large number of salivary cotinine concentrations and it is interesting that all-cause 
mortality risk was higher in passive smokers who reported no exercise. 
 
Our study has some notable strengths and limitations. The main strengths are the large sample size and the 
assessment of cause-specific mortality. All surveys are susceptible to non-response bias; however, the HSE 
and SHS samples are weighted in order to be representative of the populations living in private households.40   
Exercise and smoking were only assessed at baseline and we cannot account for any changes in these 
behaviours over time. Questionnaires and accelerometers can be used to assess physical activity and both 
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methods have their advantages and disadvantages.41 It has been suggested that questionnaires remain the 
mainstay of established surveillance studies.41 Questionnaires were used in the present surveillance studies 
and it is noteworthy that questionnaires are particularly advantageous in the assessment of exercise as they 
help respondents recall vigorous-intensity activities with some accuracy.42 Accelerometers do not capture 
cycling and have to be removed during swimming and contact sports.41 It is perhaps for these reasons that 
there is poor agreement between questionnaires and accelerometers in surveys.43 No long-term measure of 
cigarette smoking was available. Mean cotinine levels were higher in smokers who did not exercise than in 
smokers who did exercise. While such a difference might suggest that those who did not exercise were heavier 
smokers than those who did, the present analyses were adjusted for smoking frequency. The Human 
Development Index (HDI) is a composite index combining indicators of longevity, knowledge and income;44 
however, HDI was not assessed in HSE or SHS. The effect estimates in the present study may have been 
overestimated or underestimated due to less-than-perfect confounder assessment.44 We cannot discount the 
possibility of reverse causation where participants with underlying disease are less likely to exercise; 
however, we excluded deaths in the first 24 months of follow-up and adjusted for longstanding illness to 
address the issue of reverse causation.  
 
In conclusion, this large population study suggests that the risks of mortality from all causes, CVD and cancer 
are reduced by approximately 30% in ex-smokers and smokers who exercise compared to those who do not. 
Exercise may be a promising way of reducing all-cause, CVD and cancer mortality in ex-smokers and current 
smokers who are unwilling or unable to quit.  
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Table 1. Participants’ characteristics at baseline (n=106,341) 
 
Variable  Exercise  
None <60 min·wk-1 ≥60 min·wk-1 
Age, years 51±17 39±14 37±13 
Male, % 43 45 57 
Cigarette smoking status    
 Never regular smoker, % 44 54 58 
 Ex-smoker, % 27 22 21 
 <10 per day, % 7 9 9 
 10 to 19 per day, % 12 10 8 
 ≥20 per day, % 10 5 4 
Ethnicity    
 White European, % 90 91 90 
 Other, % 10 9 10 
Occupation    
 Professional, % 4 7 8 
 Managerial, % 25 34 34 
 Skilled, non manual/manual, % 44 42 39 
 Semi-skilled, manual, % 20 14 14 
 Unskilled, manual, % 7 4 4 
 Other, % 0.4 0.4 0.9 
Had longstanding illness, % 49 35 29 
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Table 2. Cox proportional hazard ratios (HR) for independent associations between exercise, smoking and 
mortality (n=106,337)* 
 
 N All-cause mortality 
HR (95% CI), 
9,149 events 
CVD mortality HR 
(95% CI), 2,839 
events 
 
Cancer mortality 
HR (95% CI), 
2,634 events  
Exercise     
 None 75795 1.0 (Reference) 1.0 (Reference) 1.0 (Reference) 
 <60 min·wk-1 12611 0.72 (0.64, 0.81) 0.66 (0.53, 084) 0.85 (0.72, 1.02) 
 ≥60 min·wk-1 17935 0.69 (0.61, 0.78) 0.58 (0.44, 0.75) 0.70 (0.57, 0.86) 
 P, trend  <0.001 <0.001 <0.001 
Cigarette smoking     
 Never regular smoker 51133 1.0 (Reference) 1.0 (Reference) 1.0 (Reference) 
 Ex-smoker 26768 1.26 (1.20, 1.33) 1.11 (1.02, 1.21) 1.34 (1.22, 1.48) 
 <10 per day 7802 1.59 (1.49, 1.74) 1.27 (1.06, 1.51) 1.54 (1.29, 1.83) 
 10 to 19 per day 11459 2.10 (1.95, 2.27) 1.96 (1.71, 2.26) 2.12 (1.85, 2.43) 
 ≥20 per day 9179 2.86 (2.65, 3.08) 2.33 (2.02, 2.68) 3.09 (2.72, 3.52) 
 P, trend  <0.001 <0.001 <0.001 
 
*Models adjusted for age, sex, occupation, longstanding illness and mutually for either smoking or exercise. 
Participants who died during the first 24 months of follow-up were excluded. 
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Table 3. Cox proportional hazard ratios (HR) for combinations of exercise and smoking in relation to 
mortality (n=106,337)* 
 
Smoking 
Exercise 
≥60 min·wk-1 <60 min·wk-1 None 
All-cause mortality HR (95% CI), 9149 events   
 Never smoked 1.00 (Reference) 1.20 (0.92, 1.57) 1.56 (1.28, 1.91) 
 Ex-smoker 1.37 (1.04, 1.80) 1.30 (1.00, 1.70) 1.96 (1.61, 2.40) 
 Current smoker 2.27 (1.64, 2.18) 2.35 (1.74, 3.19) 3.38 (2.76, 4.13) 
CVD mortality HR (95% CI), 2839 events   
 Never smoked 1.00 (Reference) 0.90 (0.49, 1.64) 2.01 (1.33, 3.06) 
 Ex-smoker 1.23 (0.69, 2.19) 1.81 (1.08, 3.02) 2.19 (1.44, 3.32) 
 Current smoker 2.58 (1.33, 5.03) 2.45 (1.30, 4.64) 3.64 (2.40, 5.53) 
Cancer mortality HR (95% CI), 2634 events   
 Never smoked 1.00 (Reference) 1.73 (1.19, 2.54) 1.39 (1.02, 1.90) 
 Ex-smoker 1.57 (1.03, 2.39) 1.19 (0.76, 1.85) 1.93 (1.41, 2.63) 
 Current smoker 1.51 (0.88, 2.59) 1.96 (1.21, 3.18) 3.32 (2.44, 4.51) 
 
*Models adjusted for age, sex, occupation and longstanding illness. Participants who died during the first 24 
months of follow-up were excluded. 
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Table 4. Cox proportional hazard ratios (HR) for exercise, physical activity and mortality in ex-smokers 
(n=26,768)* 
 
 N All-cause mortality 
HR (95% CI), 3629 
events 
CVD mortality HR 
(95% CI), 1138 
events 
Cancer mortality 
HR (95% CI), 989 
events 
Exercise     
 No 20287 1.0 (Reference) 1.0 (Reference) 1.0 (Reference) 
 Yes 6481 0.70 (0.60, 0.80) 0.71 (0.55, 0.92) 0.66 (0.52, 0.84) 
Physical activity tertile     
 Lower, <6.62 MET-hr·wk-1 9566 1.0 (Reference) 1.0 (Reference) 1.0 (Reference) 
 Middle, 6.63-23.8 MET-hr·wk-1 8677 0.70 (0.65, 0.76) 0.69 (0.60, 0.79) 0.95 (0.82, 1.11) 
 Upper, >23.8 MET-hr·wk-1 8520 0.61 (0.55, 0.67) 0.55 (0.46, 0.66) 0.91 (0.77, 1.07) 
 P, trend  <0.001 <0.001 0.52 
 
*Models adjusted for age, sex, occupation and longstanding illness. Participants who died during the first 24 
months of follow-up were excluded. 
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Table 5. Cox proportional hazard ratios (HR) for exercise, physical activity and mortality in smokers 
(n=28,440)* 
 
 N All-cause mortality 
HR (95% CI), 2476 
events 
CVD mortality HR 
(95% CI), 673 
events 
Cancer mortality 
HR (95% CI), 807 
events 
Exercise     
 No 21579 1.0 (Reference) 1.0 (Reference) 1.0 (Reference) 
 Yes 6861 0.69 (0.57, 0.83) 0.66 (0.45, 0.96) 0.69 (0.51, 0.94) 
Physical activity tertile     
 Lower, <6.62 MET-hr·wk-1 9793 1.0 (Reference) 1.0 (Reference) 1.0 (Reference) 
 Middle, 6.63-23.8 MET-hr·wk-1 9340 0.75 (0.68, 0.83) 0.80 (0.66, 0.97) 0.87 (0.73, 1.03) 
 Upper, >23.8 MET-hr·wk-1 9300 0.78 (0.70, 0.86) 0.79 (0.64, 0.97) 0.97 (0.81, 1.16) 
 P, trend  0.001 0.061 0.99 
 
*Models adjusted for age, sex, occupation, longstanding illness, and smoking volume (<10 per day, 10-19 per 
day, ≥20 per day). Participants who died during the first 24 months of follow-up were excluded. 
